theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Ophthalmology

General Dermatology   

Questions discussed in this category


How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.
6 Answers available

What topical therapies do you most commonly prescribe for rashes near the eyes?
1 Answer available

What recommendations do you provide to patients who develop ocular side effects with Dupixent?
Do you refer them to Ophthalmology? Have you had to switch patients off of Dupixent due to their ocular side effects?
3 Answers available
227151568814255


Papers discussed in this category


Arthritis & rheumatology (Hoboken, N.J.), 2021 Apr 26
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.

Ophthalmology, 2016-06
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Related Topics in Ophthalmology

  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer
  • Pediatric Hematology/Oncology

Copyright © 2025 theMednet
All Rights Reserved.